Paul Tudor Jones Vaccitech PLC Transaction History

Tudor Investment Corp Et Al

  • $26.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$3.09 - $6.21 $824,804 - $1.66 Million
266,927 New
266,927 $1.19 Million
Q4 2021

Feb 14, 2022
SELL
$8.98 - $15.55 $3.4 Million - $5.88 Million
-378,260 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$14.0 - $16.5 $588,826 - $693,973
-42,059 Reduced 10.01%
378,260 $5.73 Million
Q2 2021

Aug 16, 2021
BUY
$13.03 - $17.0 $5.48 Million - $7.15 Million
420,319 New
420,319 $6.02 Million

Others Institutions Holding VACC

# of Institutions
20
Shares Held
14.9M
Call Options Held
0
Put Options Held
0
View Full List

About Vaccitech plc

VACC Quotes by TradingView
  • Ticker VACC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,216,200
  • Market Cap $127M
  • Description
  • Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B...
More about VACC
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email